REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Radicura Pharmaceuticals Private Limited (India)

Main Activities: Office Administrative Services
Full name: Radicura Pharmaceuticals Private Limited Profile Updated: December 15, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Radicura Pharmaceuticals Private Limited is an unlisted company, incorporated on 02/05/1974. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U74899DL1974PTC007245 and registration number is 007245.

Legal Address
B-289, 1St Floor & Basement, Okhla Industrial Area, Phase-1
South Delhi; Delhi; Postal Code: 110020

Contact Details: Purchase the Radicura Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Radicura Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Radicura Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Radicura Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
May 02, 1974
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
10.32%
Purchase this report to view the information.
9.97%
Company Performance
Financial values in the chart are available after Radicura Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-3.57%▼
Total operating revenue
-2.91%▼
Operating profit (EBIT)
-50.25%▼
EBITDA
-42.08%▼
Net Profit (Loss) for the Period
-64.41%▼
Total assets
-15.39%▼
Total equity
6.93%▲
Operating Profit Margin (ROS)
-0.95%▼
Net Profit Margin
-0.85%▼
Return on Equity (ROE)
-12.99%▼
Debt to Equity Ratio
38.11%▲
Quick Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo